🇺🇸 FDA
Patent

US 8394843

Substituted isoindoles as glucokinase activators

granted A61PA61P13/12A61P15/08

Quick answer

US patent 8394843 (Substituted isoindoles as glucokinase activators) held by Takeda California, Inc. expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda California, Inc.
Grant date
Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P13/12, A61P15/08, A61P3/04, A61P3/06